1. United Kingdom Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Smith & Nephew plc

Smith & Nephew plc

12.56
CHF
+1.42
(+12.79%)
Feb 23Next Earn
Smith & Nephew plc
BX:NPW1
(BX Swiss)

Recent

price

12.56

P/E

ratio

- -

div

yld

2.08%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
USD
4.46
4.79
4.61
4.83
5.17
3.85
5.33
5.44
5.62
5.87
5.22
5.95
5.85
6.37
6.66
7.11
- -
Revenue per Share
0.69
0.65
0.8
0.62
0.56
0.34
0.9
0.88
0.76
0.69
0.51
0.6
0.25
0.3
0.47
0.72
- -
Basic EPS, GAAP
0.97
0.95
1.01
0.96
0.76
0.86
0.97
1.25
1.07
1.34
1.07
1
0.52
0.7
1.13
1.48
- -
Free Cash Flow per Basic Share
0.15
0.16
0.21
0.27
0.28
0.23
0.32
0.31
0.37
0.36
0.38
0.38
0.37
0.38
0.37
0.38
0.28
Dividend per Share
3.12
3.57
4.3
4.53
4.52
4.42
4.52
5.31
5.49
5.81
6.02
6.34
6.04
5.98
6.03
6.23
4.53
Book Value per Share
1.4
1.87
1.81
1.95
0.3
0.5
0.41
1.03
1.49
0.89
0.99
1.34
1.14
1.28
1.38
1.53
0.42
Tangible Book Value per Share
888
891
897
901
893
1,203
876
875
872
875
873
876
892
871
873
867
894
Basic Weighted Avg Shares
3,962
4,270
4,137
4,351
4,617
4,634
4,669
4,765
4,904
5,138
4,560
5,212
5,215
5,549
5,810
6,164
- -
Sales/Revenue/Turnover
23.52
21.5
22.21
20.27
19.38
13.55
19.32
19.73
20.33
19.27
6.47
13.09
12.16
11.17
14.8
13.9
- -
Operating Margin (%)
273
297
312
361
427
493
463
447
435
502
545
563
548
527
555
574
- -
Depreciation Expense
615
575
721
556
501
410
784
767
663
600
448
524
223
263
412
625
- -
Net Income, GAAP
31.28
31.63
33.97
30.67
29.83
26.65
26.18
12.74
15.11
19.25
- -
10.58
5.11
9.31
17.27
19.77
- -
Effective Tax Rate (%)
15.52
13.47
17.43
12.78
10.85
8.85
16.79
16.1
13.52
11.68
9.82
10.05
4.28
4.74
7.09
10.14
- -
Profit Margin (%)
1,240
1,067
1,214
1,183
1,278
1,131
1,181
1,385
1,612
1,655
2,976
2,293
2,141
1,759
2,890
2,508
1,207
Working Capital
642
16
430
347
1,666
1,434
1,564
1,423
1,301
1,975
3,353
2,848
2,712
2,319
3,258
3,177
1,532
LT Debt
2,773
3,187
3,884
4,047
4,040
3,966
3,958
4,644
4,874
5,141
5,279
5,568
5,259
5,217
5,265
5,289
4,049
Total Equity
17.67
16.1
13.75
12.42
10.03
7.97
10.35
13.53
11.48
9.49
- -
5.83
4.92
4.6
6.3
7.26
- -
Return on Invested Capital (%)
19.79
16.98
18.49
12.98
10.46
8.15
15.09
14.11
11.63
9.77
- -
6.79
3.63
4.74
6.53
8.94
- -
Return on Capital (%)
24.84
19.3
20.39
14.02
12.39
10.24
19.79
17.83
13.93
11.98
8.6
9.66
4.12
5.02
7.86
11.84
- -
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Sep'14
Dec'14
Jun'15
ST Debt
91
39
66
LT Borrowings
1,936
1,656
- -
LT Finance Leases
- -
10
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
894
894
894
Market Capitalization
- -
- -
- -

Working Capital

USD

•

in mil. unless spec.
Sep'14
Dec'14
Jun'15
Total Current Assets
2,529
2,440
2,432
Cash, Cash Equivalents & STI
147
93
88
Accounts Receivable, Net
1,173
968
1,159
Inventories
1,209
1,181
1,185
Total Current Liabilities
1,228
1,162
1,225
Payables & Accruals
- -
- -
- -
ST Debt
91
39
66
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.07%
0.1%
0.46%
Free Cash Flow
7.13%
13.92%
30.19%
Net Income, GAAP
12.65%
17.16%
51.7%
Sales/Revenue/Turnover
3.08%
6.31%
6.09%
Total Cash Common Dividend
- -
- -
0.92%

Semi-annual Revenue

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
5,549
2024
- -
- -
5,810
2025
- -
- -
6,164

Semi-annual Earnings Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.3
2024
- -
- -
0.47
2025
- -
- -
0.72

Semi-annual Dividends Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.38
2024
- -
- -
0.37
2025
- -
- -
0.38
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Smith & Nephew plc develops, manufactures, markets and sells medical devices and services focused on the repair, regeneration and replacement of soft and hard tissue. The company operates through three global business units: Orthopaedics, offering hip, knee and shoulder implants for joint replacement procedures, robotics-assisted enabling technologies such as the CORI Surgical System, trauma and extremities products for fracture stabilization and bone deformity correction; Sports Medicine & ENT, providing advanced arthroscopy products, instruments for soft tissue repair or removal, cartilage regeneration technologies like Agili-C and ear, nose and throat solutions; and Advanced Wound Management, delivering negative pressure wound therapy systems such as PICO, antimicrobial dressings, biological products and skin substitutes to address complex clinical needs and reduce wound-related consequences. Founded in 1856 and headquartered in Watford, Hertfordshire, UK, Smith & Nephew employs approximately 18,000 people and conducts operations in more than 100 countries, serving hospitals, clinics and healthcare professionals worldwide with annual sales of $5.8 billion in 2024. Recent developments include a multi-year extension of its partnership with UFC as the Preferred Sports Medicine Technology Partner announced in October 2025, building on the 2024 agreement to promote health and safety advancements in combat sports; revised plans in 2024 for a new 23-acre research, development and manufacturing site in Melton, UK, under an £80 million project while retaining certain Hull facilities amid cost increases; completion of the CartiHeal acquisition in early 2024 to bolster knee cartilage regeneration capabilities; and implementation of a 12-Point Plan driving revenue growth as evidenced by third-quarter 2025 results.

Company News

Company News APIChatGPT

  • zacks.com

    Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets

  • globenewswire.com

    Smith+Nephew's revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal

  • globenewswire.com

    Smith+Nephew lanza en Europa el innovador implante de reparación de cartílago CARTIHEAL™ AGILI-C™, que será protagonista en el Congreso ICRS de Portugal

  • globenewswire.com

    Smith+Nephew lancia in Europa CARTIHEAL™ AGILI-C™, l'innovativo impianto per la riparazione della cartilagine, che sarà presentato all'ICRS Summit in Portogallo.

  • zacks.com

    Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care

  • defenseworld.net

    Smith & Nephew SNATS (NYSE:SNN) Reaches New 52-Week Low – Time to Sell?

  • globenewswire.com

    MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management

  • globenewswire.com

    Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management

  • globenewswire.com

    Smith+Nephew to showcase leading shoulder technologies for joint repair and reconstruction at ICSES 2026

  • accessnewswire.com

    Smith & Nephew Plc Announces Result of Cash Tender Offer for 2030 Bonds

  • accessnewswire.com

    Smith & Nephew Plc Announces Pricing of Cash Tender Offer for 2030 Bonds

  • gurufocus.com

    Is It Too Late to Buy Smith & Nephew PLC (SNN) After 3.3% Rally? GF Value Says Undervalued

  • defenseworld.net

    Smith & Nephew SNATS (NYSE:SNN) Hits New 52-Week Low Following Analyst Downgrade

  • accessnewswire.com

    Smith & Nephew Plc Announces Cash Tender Offer for 2030 Bonds Up To $250m

  • proactiveinvestors.co.uk

    Smith & Nephew keeps Jefferies 'buy' despite H2 growth scepticism

  • proactiveinvestors.co.uk

    Panmure Liberum cuts Smith & Nephew target price after disappointing results and CFO exit

  • proactiveinvestors.co.uk

    UBS cuts Smith & Nephew target on competitive threats to three franchises

  • defenseworld.net

    BlackRock Inc. Invests $505.32 Million in Smith & Nephew SNATS, Inc. $SNN

  • zacks.com

    SNN Advances Surgical Robotics Through Imperial College Partnership

  • proactiveinvestors.co.uk

    Smith & Nephew shares slip on CFO's departure